Abstract

Enteroviruses are small RNA viruses that affect millions of people each year by causing an important burden of disease with a broad spectrum of symptoms. In routine diagnostic laboratories, enteroviruses are identified by PCR-based methods, often combined with partial sequencing for genotyping. In this proof-of-principle study, we assessed direct RNA sequencing (DRS) using nanopore sequencing technology for fast whole-genome sequencing of viruses directly from clinical samples. The approach was complemented by sequencing the corresponding viral cDNA via Illumina MiSeq sequencing. DRS of total RNA extracted from three different enterovirus-positive stool samples produced long RNA fragments, covering between 59% and 99.6% of the most similar reference genome sequences. The identification of the enterovirus sequences in the samples was confirmed by short-read cDNA sequencing. Sequence identity between DRS and Illumina MiSeq enterovirus consensus sequences ranged between 94% and 97%. Here, we show that nanopore DRS can be used to correctly identify enterovirus genotypes from patient stool samples with high viral load and that the approach also provides rich metatranscriptomic information on sample composition for all life domains.

Highlights

  • IntroductionEVs are associated with a wide variety of symptoms, ranging from mild respiratory diseases to severe neurological infections, leading potentially to death [2]

  • Enteroviruses (EVs) present a major burden for human health and health care systems worldwide, with large outbreaks consisting of hundreds of thousands of hospitalized cases occurring periodically [1].EVs are associated with a wide variety of symptoms, ranging from mild respiratory diseases to severe neurological infections, leading potentially to death [2]

  • direct RNA sequencing (DRS) was performed with enterovirus-positive stool samples with similar viral load (Ct values between 18 and 23) in three independent experiments, consisting of samples from three different patients

Read more

Summary

Introduction

EVs are associated with a wide variety of symptoms, ranging from mild respiratory diseases to severe neurological infections, leading potentially to death [2]. These single-stranded RNA viruses that belong to the Picornaviridae family possess a relatively small genome size ranging from 7.2 to 8.5 kb. EV presence is generally determined by real-time, reverse-transcription PCR (qRT-PCR). Assays, complemented by partial sequencing of the VP1–VP4 coding regions for genotyping [2,3]. When diagnostic tests solely rely on PCR using conserved primer sequences, false-negative results cannot be excluded

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call